ABSTRACT BACKGROUND: Major depressive disorder (MDD) exhibits numerous clinical and molecular features that are consistent with putative epigenetic misregulation. Despite growing interest in epigenetic studies of psychiatric diseases, the methodologies guiding such studies have not been well defined.
Major depressive disorder (MDD) is a psychiatric disease characterized by an all-encompassing low mood accompanied by low self-esteem, loss of interest or pleasure in normally enjoyable activities, and a variety of other associated symptoms (1) . MDD affects one in seven individuals (2) and has been projected to become the second leading cause of disability worldwide by 2020 (3) .
A meta-analysis of twin studies on MDD estimated heritability at 37% (4) , which is consistent with a recent large epidemiologic study (5) . This significant heritability provided a basis for molecular genetic studies; however, identification of specific MDD risk genes has proven difficult. A recent genome-wide association study with .18,000 subjects in the discovery phase did not detect any genome-wide significant single nucleotide polymorphisms (SNPs). The study followed up on the top 554 SNPs (p , .0001) in an independent set of .57,000 subjects but failed to replicate any of the SNPs at genome-wide significance (6) .
MDD exhibits numerous non-Mendelian features that can be reviewed from an epigenetic perspective (7) . Such features include partial heritability, discordance of monozygotic (MZ) twins, sexual dimorphism (8, 9) , disease onset following major hormonal changes (e.g., postpartum depression) (10) , and fluctuating course of disease (11) . Epigenetics refers to the regulation of various genomic functions that are controlled by heritable but reversible chemical modifications of DNA and histones (12) . Environmental factors such as stress, diet, and drugs can alter the epigenetic profile (13, 14) . Even in the absence of environmental exposures, stochastic epigenetic changes may influence phenotypic outcomes (15) . Furthermore, there is increasing evidence that epigenetic factors, in addition to DNA sequences, account for heritability (16, 17) . In short, we postulate that inherited and acquired epigenetic misregulation may play an etiological role in MDD (7) .
In this study, we attempted to identify MDD specific epigenetic changes using a series of experimental and analytical approaches, from traditional locus-by-locus comparisons to new systems biology-based strategies, such as epigenomic networks and machine-learning based classification.
METHODS AND MATERIALS Samples
Tissue samples were collected from individuals diagnosed with MDD and from matched control subjects. Inclusion criteria involved patients between the ages of 18 and 75 diagnosed with MDD according to DSM-IV criteria. Individuals with a prior history of other mental illnesses, addiction and substance abuse, or a family history (first-degree relatives) of schizophrenia were excluded from the study. The 100 discordant MZ twin samples consisted of peripheral blood DNA from 40 pairs of MZ twins from Australia, 46 pairs from The Netherlands, and 14 pairs from the United Kingdom (for detailed description, see Supplement 1). Seventy-one prefrontal cortex samples were received from the Stanley Medical Research Institute (SMRI) and Quebec Suicide Brain Bank (QSBB). Thirty-three sperm samples from bipolar disorder patients, a disease that may be etiologically related to MDD (18, 19) , and control subjects were obtained from an ongoing study at the Centre for Addiction and Mental Health (Toronto, Ontario, Canada). More information on the samples can be found in Table S1 in Supplement 1.
Microarray Experiment
The unmodified DNA fraction was enriched using modified cytosine ( mod C)-sensitive restriction enzymes, which collectively interrogate 5-methylcytosine and 5-hydroxymethylcytosine (20) (it is assumed that 5-carboxylcytosine and 5-formylcytosine are rare and unlikely to significantly contribute to the estimates of the modified/unmodified cytosines). Three aliquots of 250 ng of genomic DNA were digested individually with HpaII, HinP1I, and HpyCH4IV and pooled together after digestion was completed. For the twin samples, 500 ng of genomic DNA was digested using only HpaII. All other steps were identical to those described in our published protocol (21) . The microarray experiment was conducted using a common reference pool design. The enriched polymerase chain reaction products were labeled with Cy3 for the reference and Cy5 for the sample hybridized onto 8.1K human CpG island microarrays (22, 23) . A detailed description of the bioinformatic methods can be found in Supplement 1.
Bisulfite modification and pyrosequencing-based fine mapping of mod C was performed using a standard protocol (24) . The primers for the bisulfite polymerase chain reaction were designed using either the MethPrimer (25) or the Pyrosequencing Assay Design Software v1.0.6 (Qiagen, Valencia, California) (Table S2 in Supplement 1). For pyrosequencing, Gold Q96 Reagents and Pyromark Q24 were used (Qiagen).
Ethics Statement
Centre for Addiction and Mental Health Research Ethics Board granted approval to protocol # 024/2005-01 entitled "Molecular epigenetic studies of major depression." All experiments were performed in accordance with relevant guidelines and regulations.
RESULTS
Locus-Specific Analysis of DNA Modification in the Brain, White Blood Cells, and the Germline
In the human brain samples from the SMRI, a locus-by-locus comparison between MDD or MDD with psychosis (MDD 1 Psy) and control subjects using analysis of variance revealed 40 differentially modified loci (nominal p 5 4 3 10 25 2 .01; Table S4 in Supplement 1); 22 loci showed differential modification between MDD and control subjects, and 18 loci showed differential modification between MDD 1 Psy and control subjects (Tukey's honestly significant difference, p , .05). Eight loci were differentially modified for both MDD and MDD 1 Psy compared with control subjects. One gene, FOXD3, was previously implicated in MDD (26) . The analysis of the brain samples from the QSBB revealed 35 loci with differential modification (nominal p 5 5 3 10 24 2 .01). In white blood cells (WBCs) from MZ twins discordant for MDD, we identified 44 loci with nominal p 5 9 3 10 25 2 .01. Lastly, in the sperm samples from individuals affected with bipolar disorder and control subjects, we found 34 loci (nominal p 5 6 3 10 24 2 .01), one of which had already been implicated in bipolar disorder (SMAD3) (27) .
We did not find significant overlaps between any of the samples tested above. However, we found a statistically significant number of overlapping loci between our study and a previously published epigenome-wide study using the same SMRI brain samples but different enrichment technique and platform (at nominal p , .05 for both studies) (28) . We performed permutation analysis and found that our microarray probes that were either directly on or nearest neighbors (median distance 5 12 kb) to the gene of interest were overrepresented than by chance (n 5 14; permuted p 5 .04; Table S5 in Supplement 1). Even when the parameters were made more stringent to only include microarray probes that were either directly on or within a short distance away (,10 kb or ,5 kb) from the gene of interest, we still found a significant number of overlaps between the two studies (n 5 12 for both; p 5 .03 and p 5 .02, respectively).
None of the detected loci survived correction for multiple testing, although 13 loci with nominal p , .05 overlapped with either the SMRI or the QSBB brain samples and the WBC samples of the MDD twins. Among the 13 loci, probes for LRRC41 and LIN28A contained regulatory sequences, nuclear factor-κB transcription factor binding site, and a predicted insulator CTCF binding site, with mod C sensitive sites ( Figure 1 ) (29) . These two loci, plus three different types of repetitive elements (LINE-1, NBL-2, and D4Z4) as proxies for global modification changes (30) , were finely mapped using bisulfite pyrosequencing. A total of 29 CpG sites (11, 4, 3, 6 , and five CpG sites for LRRC41, LIN28A, LINE-1, NBL-2, and D4Z4, respectively) were interrogated from the two unique DNA loci and three repetitive DNA elements.
Bisulfite pyrosequencing revealed that mod C density at LIN28A was different in the SMRI MDD 1 Psy samples compared with control subjects (Mann-Whitney test, p 5 .01). While the pooled MDD samples (MDD and MDD 1 Psy) also showed significant differences (p 5 .01), MDD alone versus control subjects did not reach significance (p 5 .08), and the same was detected in the QSBB samples (p 5 .77). We also (31, 32) , the average density of mod C was similar in MDD patients and control subjects across the three repetitive DNA elements tested (Table S6 in Supplement 1) .
Next, we attempted to understand why the conventional mean difference-based analysis uncovered only minor epigenetic changes in MDD and investigated two confounding factors: putative MDD heterogeneity and age effects.
Effects of the Degree of MZ Twin Discordance and Age-Dependent Heteroscedasticity of DNA Modification
Despite the obvious advantages of discordant MZ twin design in epigenomic studies, the unaffected co-twins are at a higher risk for MDD than the general population (33, 34) ; therefore, they may carry some epigenetic risk factors, which reduces the power of detection of disease-specific epigenetic differences. To test this hypothesis, we analyzed subgroups of MZ twins with differing degrees of discordance for MDD. We utilized twin discordance information derived from the personality questionnaires, reported number of episodes, and interviews of the MZ twins to separate the most discordant from least discordant (35) . The severity of disease discordance between the MZ twins indeed played a role; when we performed t tests using the 10 most discordant MZ pairs, we found 165 significant loci with nominal p , .05 but only 81 in the 10 least discordant pairs (Fisher's exact test, p 5 3.3 3 10
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). The two middle groups of discordant twins showed an intermediate number of statistically significant differences ( Figure 2A ).
Another factor that may have compromised identification of significant epigenetic differences was age-dependent inconsistency in the variance of mod C. This phenomenon, generally known as heteroscedasticity, occurs when subsets of the samples have different degrees of variability. In the Australian MDD twins, we found 489 loci that exhibited changing variance with age in both the affected and the unaffected co-twins (Harrison-McCabe test, false discovery rate, q , .05) ( Figure 2B ). The majority (76%) of the heteroscedastic loci showed increasing mod C variance with age. To verify if this phenomenon had an impact on statistical power, we performed t tests only on the heteroscedastic loci after separating the dataset into two groups by age: the younger half (32.1 6 4.6 years; mean age 6 SD) and the older half (50.3 6 8.5 years). We found more differing loci between the affected and the unaffected twins in the younger group compared with the older group (20 and 9, respectively; Fisher's exact test, p 5 .004), indicating that age-dependent heteroscedasticity reduces statistical power ( Figure 2C ).
MDD DNA Modification Differences Detected in More Than One Tissue
To identify MDD epigenetic features that were common across tissues, we analyzed the largest mod C differences (. 
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), among which NLGN1 was previously implicated in MDD (36) . Gene Ontology (GO) enrichment analysis of overlapping loci across different tissues showed enrichment of terms related to cell proliferation on forebrain, fat cell differentiation, and glutamate signaling pathway, among others (Table S7 in Supplement 1).
Epigenetic Outliers Are More Prevalent in MDD Patients
We defined samples as epigenetic outliers if the mod C for a given locus deviated substantially from the average mod C value of the overall sample. The outliers were categorized into three groups: gene coding, intergenic, and those mapping to regions of known copy number variants, which may generate false evidence for epigenetic outliers (Figure 4 ). In the gene coding regions, we found 3123 outliers in the affected MZ twins and 2747 in the unaffected co-twins (Fisher's exact test, p 5 2.2 3 10
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). In the intergenic regions, there were 1576 outliers in the affected twins and 1444 in the unaffected co-twins (Fisher's exact test, p 5 3 3 10
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). No significant difference was detected in the number of outliers between MDD twins (n 5 42) and co-twins (n 5 39) in the copy number variant regions. The outliers were not driven by a small subset of individuals; rather, they were the products of small contributions from numerous individuals over many loci. On average, each affected and unaffected co-twin contributed 15.3 6 26.8 and 14.8 6 27.2 (mean 6 SD) outliers, respectively.
Epigenomic Network Analysis
We performed two types of network analysis. The first was a weighted correlation network utilizing continuous personality traits associated with MDD. Some personality dimensions are good predictors of MDD risk and prognosis (37) (38) (39) , and we applied these continuous phenotypes in the network analysis (40) . This approach avoids the loss of power that stems from dichotomizing individuals into affected and control groups, as well as excessive correction for multiple comparisons (41, 42) . The scales of the personality tests administered at the twin registries were not directly comparable, so each twin group (Dutch, United Kingdom, and Australian) was analyzed separately.
The network analysis revealed modules (groups of loci correlating for DNA modification) that were related to personality dimensions (neuroticism, extraversion, or anxiety) in all the twin groups. In the Dutch twins, we identified 33 modules, 2 of which correlated with the personality dimensions neuroticism Figure 2 . Effects of major depressive disorder twin discordance and age on the number of DNA modification differences in white blood cells. (A) Each data point represents a group of 20 twins (10 sets), from the most discordant twins on the left to the least discordant twins on the right. The number of loci found to be significant using t test decreases as the twins become less discordant. Fisher's exact test showed that the number of loci detected as significant were higher in the more discordant twin groups compared with least discordant group. 24 and p = .01 for the first and second modules, respectively) and extraversion (p = 6.0 3 10 24 and p = .03). GO analysis of the first module showed enrichment of terms related to postsynaptic membrane, synapse, and postsynaptic density, while the second module was related to lipid metabolic process, glycolipid metabolic process, and response to insulin stimulus (Table S7 in Supplement 1). In the United Kingdom twins, 15 modules were identified, 1 of which correlated with neuroticism and 2 others correlated with anxiety (p 5 .004, p 5 .01, and p 5 .03, respectively). The GO terms for these modules were related to heart development, methionine metabolic process, and forebrain formation, respectively. In the Australian twins, 1 module (out of 17) showed a significant correlation with extraversion (p 5 .03) and enrichment of terms related to Rho guanosine triphosphate (GTP)ase binding, one of a number of critical processes in neuronal migration.
The second network-based approach was partial correlation analysis, which eliminates indirect relationships (i.e., correlation between two variables that is mediated by a third variable) to reveal true interactions between loci (43). The partial correlation network revealed differences in the network property ( Figure 5 ); affected MZ twins had a larger number of edges compared with their unaffected twins (n 5 1453 and n 5 1196, respectively), despite having similar number of nodes (n 5 691 and n 5 686, respectively). We also observed that a significant number of nodes, in both the affected and normal networks, overlapped with the differentially modified loci in the brain cortex and the sperm (see MDD DNA Modification Differences Detected in More Than One Tissue). Of the 110 overlaps identified between the cerebral cortex and the sperm, we saw 34 overlapping nodes in the network of affected individuals and 27 in the control network (binomial test, p 5 2.2 3 10 216 and p 5 3.0 3 10 211 , respectively). Many of the overlapping nodes were common in both the affected (25 of 34 nodes) and the normal network (25 of 27 nodes) (Table S8 in Supplement 1). Between 691 nodes from the affected network and 686 nodes from the normal network, there were 308 common nodes, which suggest commonality between the affected individuals and the control subjects. GO enrichment analysis of the common nodes showed enrichment of terms related to development and homeostasis (Table  S7 in Supplement 1). Lastly, we found that the differentially modified loci between MDD patients and control subjects may act as hubs (i.e., nodes with high number of edges) in the network ( Figure 3B,C) . When we investigated the top 100 hubs, we found that 14 hubs overlapped with loci that were previously identified to be modified across multiple tissues (binomial test, p 5 1.9 3 10 213 ), more specifically, the ones that were overlapping between the cortex and the sperm.
Discriminant Analysis of MDD Patients and Control Subjects
The discriminant analysis showed that most samples could be classified with high discrimination power when analyzed within the same tissue type (Table S9 in Supplement 1). The affected and control samples were divided into two groups, learning or 
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DNA Modification Study testing, using stratified random sampling. The informative array probes that could distinguish MDD patients and control subjects (Table S3 in Supplement 1) were selected from the learning group using a correlation-based feature subset selection. Using the informative loci (attributes) selected from the learning group in the combined SMRI and QSBB brain samples, we were able to correctly classify 76% to 81% of the individuals in the testing set according to their phenotype with receiver operating characteristic (ROC) areas of .77 to .82.
The blood samples, on the other hand, showed conflicting results. In the analysis using all the twin samples (Australian, United Kingdom, and Dutch), we were unable to discriminate affected individuals from control subjects. However, when the samples were separated into European and Australian twins and treated independently, we were able to obtain ROC of .62 to .84 for the European twin samples. However, the model based on the Australian twins reverse classified cases and control subjects (ROC of .24 to .46).
Finally, we evaluated the cross-tissue classification of the model (i.e., attributes selected from sperm and tested on cortex). If an organism-wide epimutation is present, the algorithm should be able to correctly classify the phenotypes of the testing set, despite the presence of tissue-specific mod C patterns. Interestingly, models created using attributes selected from the bipolar disorder germline samples were able to classify cortex samples from the SMRI and QSBB; the ROC ranged from .52 to .76. The results improved when only the QSBB samples were classified; 73% to 75% of the cases and control subjects were sorted correctly (ROC of .78 to .95). One of the informative probes represented EMX2, a gene that was previously implicated in MDD (44) .
DISCUSSION
Overall, our locus-by-locus analysis yielded a number of modest mod C differences across multiple loci, none of which survived correction for multiple testing. Verification by bisulfite sequencing confirmed significant mod C differences, which showed effect sizes that were comparable with previous epigenetic studies of psychiatric disorders (28, 45) . Some of our detected genes have been previously implicated in MDD (26, 36, 44) . In addition, we identified a significant overlap of differentially modified genes between this and another epigenetic study of MDD (28) . This is quite remarkable considering the numerous differences between the two studies (such as microarray platforms, target probes, enrichment strategies, and data analyses) and could serve as an independent validation of mod C in MDD using the same tissue but different technical platforms.
Our study shows that the reasons why the locus-specific analysis has not resulted in significant markers for MDD may include: 1) putative MDD heterogeneity; 2) excessively conservative correction for multiple testing; and 3) age-dependent increase in variation of mod C, which we referred to as agedependent heteroscedasticity. Despite the challenges and complexities, epigenomic studies can utilize an arsenal of analytical approaches much larger than in DNA studies. For example, we performed replication of brain findings using non-brain tissues: WBC of MZ twins and germline of bipolar disorder patients. We showed that differentially modified regions exhibited a highly significant number of overlaps across the three tested tissues (binomial test, p 5 8.0 3 10 28 to p 5 2.5 3 10
24
). We also sought epigenetic outliers-rare epigenetic differences that are detected only in one or several individuals from the entire sample. The number of outliers in the group of MDD patients (n 5 4741) significantly exceeded the number of outliers in the control subjects (n 5 4230). A recently published study found higher variance of DNA modification in the group of affected MDD twins compared with the unaffected co-twins (46) , which is consistent with our current observation. Our finding adds to the observation that variation of modification, rather than the differences in mean, plays a role in disease (47) .
To fully utilize available phenotypic information, we used network analysis in conjunction with quantitative trait data. We were able to extract new information by comparing changes in mod C patterns of co-regulated genes with continuous MDD traits of neuroticism and extraversion (37, 48, 49) . We identified enrichment of pathways related to synaptic and lipid metabolic processes that correlated with neuroticism and extraversion and a methionine metabolic process that correlated with anxiety. Also, the synaptic pathway consists of genes related to glutamate receptors and aberrant metabolism, both of which have been implicated in MDD (50, 51) . Furthermore, the methionine metabolic pathway has been similarly implicated in that supplementation of a methyl group donor, S-adenosylmethionine, has been suggested as a treatment for MDD (52) . We also found that pathways related to heart development, forebrain anterior/posterior pattern formation, and Rho GTPase binding may also play a role in personality traits such as neuroticism, extraversion, and anxiety. Rho GTPase activating protein 6 was found to be differentially expressed in suicide completers (53) and disruption of pathways involving Rho GTPase activation has been associated with MDD and bipolar disorder (54, 55) .
Another type of network, the partial correlation network, showed that many of the nodes were shared between the networks of MDD and control individuals. The shared nodes overlapped with differentially modified loci across different tissues and played an important role as hubs in the network. Further analysis showed that the nodes were preferentially enriched for loci with high coefficients of variation. Therefore, our current observation suggests that differential mod C in MDD occurs in more variable regions of the genome that may be related to development and homeostasis.
Finally, we used a combination of small mod C differences to classify the phenotypes using machine-learning algorithms. In most cases, we were able to accurately classify the samples into the correct phenotypes within the same tissue type. Furthermore, we were able to use attributes selected from the germline samples to correctly classify up to 75% of the postmortem brain samples of MDD patients. These findings may point to a heritable epigenetic basis for MDD and bipolar disorder, although they may also reflect epigenetic effects of treatment or some other disease-related phenomenon.
In other cases, discriminant analysis showed conflicting results. Although we were able to correctly classify 70% to Normal network Affected network DNA Modification Study 81% of the European twins, we were unable to discriminate the Australian twins. One likely explanation for the different results may be related to environmental variation. In fact, twin studies have detected that the influence of the shared environment was substantially greater in Dutch MZ twins as compared with Australian MZ twins (in the old cohort, 46% and 10%, respectively), and the different outcomes were attributed to the differences in population densities (56, 57) . Accordingly, we might expect the following: the lower the contribution of shared environment, the higher the degree of epigenetic variation.
For WBC-based study, it is possible that blood cell count differences may simulate epigenetic false positives (17) . However, it is unlikely that our findings are epigenetic artifacts. Using gene expression data as a proxy for DNA modification, there were 1150 genes uniquely expressed in either B cells, CD41 T cells, CD81 T cells, lymphocytes, or granulocytes (58); only 2.15% of these genes were represented in the 8.1K human CpG island microarray.
Some of the epigenetic differences detected in MDD patients compared with control subjects may, in fact, be induced by the treatment (59) (60) (61) . We cannot exclude the possibility that the surprisingly successful classification of brain samples using germline mod C profiles may reflect organism-wide treatment effects. Such hypotheses may open new and important research avenues: how different medications affect the germline, how drug-induced epigenetic changes can be transmitted to the next generation, and how such changes may affect the health of the offspring.
We have explored numerous aspects of how DNA modification may be involved in MDD, identified several areas that need further consideration, and introduced a number of new methods. There are several limitations in this study, which should be considered and addressed in the future. Enrichment techniques should distinguish various types of cytosines (unmodified cytosine, 5-methylcytosine, 5-hydroxymethylcytosine, 5-carboxylcytosine, and 5-formylcytosine) and these multiple layers of epigenome should be interrogated using high-resolution techniques and platforms covering the entire genome. With increasing numbers of interrogated genes and loci, larger samples will be necessary to deal with severe penalties for multiple testing. Samples with balanced male to female ratio may help to uncover sex-specific predisposition to MDD. The issue of cellular heterogeneity remains open in epigenomic studies of brain diseases. Separation of neuronal from nonneuronal brain cells is only a partial solution, as it cannot distinguish different types of neurons and different types of nonneuronal cells.
Despite the complexities inherent in human studies, this work demonstrates that application of new analytical approaches may significantly advance the field of psychiatric epigenomics.
